1. Detection of Mycobacterium tuberculosis complex DNA in CD34-positive peripheral blood mononuclear cells of asymptomatic tuberculosis contacts: an observational study
- Author
-
Sally Forrest, Julie Demaret, Tenagnework Abozen, Begna Tulu, Jonathan Mayito, Metasebia Tegegn, Stephen T Reece, Abraham Aseffa, Emawayish A. Tirfie, Hana Manwandu, Dawit Tayachew, Denise M. O'Sullivan, Adrian R. Martineau, Kathryn A. Harris, Aboma Zewude, Gobena Ameni, Martin Vordermeier, Jim F. Huggett, Gerwyn M. Jones, Taye Tolera Balcha, Stefan Berg, Mulugeta Belay, Aneesh Chandran, Markos Abebe, Sidra Younis, Vlad Nikolayevskyy, Henny M. Martineau, Mahdad Noursadeghi, and David A. Jolliffe
- Subjects
Microbiology (medical) ,Tuberculosis ,HIV Infections ,Microbiology ,Asymptomatic ,Peripheral blood mononuclear cell ,Latent Tuberculosis ,Virology ,Isoniazid ,medicine ,Humans ,Digital polymerase chain reaction ,Prospective Studies ,Index case ,biology ,Latent tuberculosis ,Tuberculin Test ,business.industry ,DNA ,Articles ,Mycobacterium tuberculosis ,biology.organism_classification ,medicine.disease ,Cross-Sectional Studies ,Infectious Diseases ,Mycobacterium tuberculosis complex ,Immunology ,Leukocytes, Mononuclear ,Ethiopia ,medicine.symptom ,business ,medicine.drug - Abstract
Summary Background Haematopoietic stem cells expressing the CD34 surface marker have been posited as a niche for Mycobacterium tuberculosis complex bacilli during latent tuberculosis infection. Our aim was to determine whether M tuberculosis complex DNA is detectable in CD34-positive peripheral blood mononuclear cells (PBMCs) isolated from asymptomatic adults living in a setting with a high tuberculosis burden. Methods We did a cross-sectional study in Ethiopia between Nov 22, 2017, and Jan 10, 2019. Digital PCR (dPCR) was used to determine whether M tuberculosis complex DNA was detectable in PBMCs isolated from 100 mL blood taken from asymptomatic adults with HIV infection or a history of recent household or occupational exposure to an index case of human or bovine tuberculosis. Participants were recruited from HIV clinics, tuberculosis clinics, and cattle farms in and around Addis Ababa. A nested prospective study was done in a subset of HIV-infected individuals to evaluate whether administration of isoniazid preventive therapy was effective in clearing M tuberculosis complex DNA from PBMCs. Follow-up was done between July 20, 2018, and Feb 13, 2019. QuantiFERON-TB Gold assays were also done on all baseline and follow-up samples. Findings Valid dPCR data (ie, droplet counts >10 000 per well) were available for paired CD34-positive and CD34-negative PBMC fractions from 197 (70%) of 284 participants who contributed data to cross-sectional analyses. M tuberculosis complex DNA was detected in PBMCs of 156 of 197 participants with valid dPCR data (79%, 95% CI 74–85). It was more commonly present in CD34-positive than in CD34-negative fractions (154 [73%] of 197 vs 46 [23%] of 197; p
- Published
- 2021